Viewing Study NCT05344833


Ignite Creation Date: 2025-12-25 @ 2:41 AM
Ignite Modification Date: 2025-12-29 @ 3:41 AM
Study NCT ID: NCT05344833
Status: RECRUITING
Last Update Posted: 2025-08-06
First Post: 2022-04-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma
Sponsor:
Organization: